| Literature DB >> 28935509 |
Mohamad Bashir1, Amer Harky2, David Bleetman2, Benjamin Adams2, Neil Roberts2, Damian Balmforth2, John Yap2, Kulvinder Lall2, Alex Shipolini2, Aung Oo2, Rakesh Uppal2.
Abstract
Management of aortic valve disease and, in particular, aortic valve stenosis has evolved through the course of time from medical management and balloon valvuloplasty to the presumed gold-standard surgical intervention. However, with the advent of surgical innovation, intra- and postoperative patients monitoring, understanding of hemodynamic dysfunction, and choices of prosthesis, conventional surgical aortic valve replacements are currently being challenged in particular in moderate- and high-risk patients. Although the long-term results and survival are not robustly available, the durability of the new prosthesis, repair, and the freedom from reoperation remain debatable. In this review, we aim to highlight the surgical innovation attained, choices of aortic valve prosthesis, and also dwell on the current evidence, practice, and trend steered to managing patients with aortic valve stenosis.Entities:
Keywords: TAVR; aortic valve; minimal invasive; sutureless; valvular heart disease
Mesh:
Year: 2017 PMID: 28935509 DOI: 10.1053/j.semtcvs.2017.08.003
Source DB: PubMed Journal: Semin Thorac Cardiovasc Surg ISSN: 1043-0679